Agitation in Participants With Dementia of the Alzheimer's Type
1 clinical trials · Condition
◉ Watch Agitation in Participants With Dementia of the Alzheimer's Type
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type (NCT02442778) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-11-11 |
Track Agitation in Participants With Dementia of the Alzheimer's Type automatically
Every clearance here is in the API, with alerts when new ones post.